A History of Left Atrial Appendage Occlusion

David Holmes, Robert S. Schwartz, George G. Latus, Robert A. Van Tassel

Research output: Contribution to journalReview article

3 Scopus citations

Abstract

A new era in antiembolic therapy has been initiated by the growing numbers of device-based therapies. Early concerns surrounding eliminating this enigmatic structure have not proven true. Other benefits are being further evaluated. Many other questions remain, such as whether there is a device-specific outcome effect or whether it is a class effect. Other questions include other devices, what head-to-head studies will show, and the impact of residual leak. Left atrial appendage using the Watchman ablation strategy can reduce cardioembolic stroke, with comparable or fewer adverse effects by device technology than obtained by long-term anticoagulation with its attendant bleeding risks.

Original languageEnglish (US)
Pages (from-to)143-150
Number of pages8
JournalInterventional Cardiology Clinics
Volume7
Issue number2
DOIs
StatePublished - Apr 1 2018

Keywords

  • Antiembolic therapy
  • Atrial fibrillation
  • Left atrial appendage
  • Watchman ablation strategy

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'A History of Left Atrial Appendage Occlusion'. Together they form a unique fingerprint.

  • Cite this